Clinical Trial Update: Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access [NA]

View source ↗

Summary

The study assessed safety and efficacy of a paclitaxel-eluting vascular wrap for hemodialysis access. The trial was terminated and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Paclitaxel-eluting vascular wrap (paclitaxel-eluting vascular wrap)

Snippet

Sponsor: Angiotech Pharmaceuticals | Conditions: Kidney Diseases, ESRD | NA | Status: TERMINATED | Results posted: 2011-11-17